| Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
| Tacrolimus Binding Proteins | 27 | 2023 | 43 | 6.090 | Why? | 
| HSP90 Heat-Shock Proteins | 19 | 2023 | 47 | 4.590 | Why? | 
| Molecular Chaperones | 16 | 2023 | 61 | 2.880 | Why? | 
| Receptors, Androgen | 12 | 2019 | 126 | 2.800 | Why? | 
| Receptors, Glucocorticoid | 7 | 2019 | 34 | 1.690 | Why? | 
| Receptors, Progesterone | 4 | 2015 | 81 | 1.340 | Why? | 
| Saccharomyces cerevisiae | 8 | 2019 | 206 | 1.110 | Why? | 
| Saccharomyces cerevisiae Proteins | 5 | 2014 | 118 | 1.050 | Why? | 
| Receptors, Steroid | 5 | 2019 | 36 | 0.920 | Why? | 
| Signal Transduction | 12 | 2019 | 1908 | 0.760 | Why? | 
| Protein Folding | 5 | 2020 | 127 | 0.750 | Why? | 
| Biological Assay | 2 | 2010 | 59 | 0.670 | Why? | 
| Zebrafish Proteins | 1 | 2019 | 47 | 0.670 | Why? | 
| Receptors, Aryl Hydrocarbon | 3 | 2004 | 48 | 0.660 | Why? | 
| Protein Binding | 12 | 2023 | 972 | 0.600 | Why? | 
| Models, Molecular | 7 | 2015 | 808 | 0.600 | Why? | 
| beta Catenin | 2 | 2015 | 48 | 0.540 | Why? | 
| Second Messenger Systems | 1 | 2015 | 14 | 0.530 | Why? | 
| Animals | 29 | 2019 | 15081 | 0.510 | Why? | 
| Carrier Proteins | 2 | 2014 | 305 | 0.490 | Why? | 
| Prostatic Neoplasms | 3 | 2015 | 935 | 0.490 | Why? | 
| Water Pollutants, Chemical | 3 | 2014 | 164 | 0.480 | Why? | 
| Endocrine Disruptors | 3 | 2014 | 39 | 0.480 | Why? | 
| Immunophilins | 4 | 2023 | 5 | 0.430 | Why? | 
| Humans | 34 | 2023 | 37093 | 0.420 | Why? | 
| Genes, Reporter | 3 | 2015 | 136 | 0.410 | Why? | 
| Mice | 17 | 2019 | 5913 | 0.390 | Why? | 
| Multiprotein Complexes | 1 | 2011 | 54 | 0.380 | Why? | 
| Amino Acid Sequence | 7 | 2015 | 1180 | 0.360 | Why? | 
| Gene Expression Regulation | 5 | 2011 | 1015 | 0.350 | Why? | 
| Estrogens | 2 | 2014 | 202 | 0.340 | Why? | 
| Molecular Sequence Data | 6 | 2015 | 1568 | 0.330 | Why? | 
| Peptidylprolyl Isomerase | 3 | 2023 | 10 | 0.320 | Why? | 
| Stress, Physiological | 2 | 2023 | 150 | 0.320 | Why? | 
| HSP70 Heat-Shock Proteins | 4 | 2023 | 47 | 0.320 | Why? | 
| Mice, Knockout | 9 | 2019 | 933 | 0.300 | Why? | 
| Binding Sites | 4 | 2015 | 651 | 0.300 | Why? | 
| Stress, Psychological | 4 | 2014 | 583 | 0.280 | Why? | 
| beta-Galactosidase | 3 | 2011 | 35 | 0.270 | Why? | 
| Hela Cells | 3 | 2015 | 366 | 0.250 | Why? | 
| Molecular Dynamics Simulation | 2 | 2019 | 133 | 0.250 | Why? | 
| Pituitary-Adrenal System | 2 | 2014 | 39 | 0.220 | Why? | 
| Adenosine Triphosphate | 1 | 2004 | 196 | 0.220 | Why? | 
| Hypothalamo-Hypophyseal System | 2 | 2014 | 53 | 0.220 | Why? | 
| Financing, Organized | 1 | 2022 | 13 | 0.220 | Why? | 
| Drug Discovery | 2 | 2015 | 82 | 0.210 | Why? | 
| Heat-Shock Proteins | 2 | 2012 | 55 | 0.190 | Why? | 
| Intramolecular Oxidoreductases | 2 | 2011 | 10 | 0.190 | Why? | 
| Yeasts | 2 | 2011 | 19 | 0.190 | Why? | 
| Phosphoproteins | 1 | 2002 | 163 | 0.190 | Why? | 
| Adaptation, Psychological | 2 | 2014 | 385 | 0.180 | Why? | 
| Protein Structure, Tertiary | 6 | 2014 | 408 | 0.180 | Why? | 
| Proline-Rich Protein Domains | 1 | 2019 | 7 | 0.180 | Why? | 
| Small Molecule Libraries | 1 | 2020 | 45 | 0.170 | Why? | 
| Orphan Nuclear Receptors | 1 | 2019 | 6 | 0.170 | Why? | 
| Environmental Monitoring | 2 | 2011 | 192 | 0.170 | Why? | 
| Anilides | 2 | 2017 | 28 | 0.160 | Why? | 
| Cyclohexanes | 2 | 2017 | 30 | 0.160 | Why? | 
| Male | 13 | 2017 | 20025 | 0.160 | Why? | 
| Protein Interaction Domains and Motifs | 2 | 2015 | 42 | 0.160 | Why? | 
| Glucocorticoids | 2 | 2016 | 86 | 0.160 | Why? | 
| Structure-Activity Relationship | 3 | 2015 | 409 | 0.160 | Why? | 
| Fibroblasts | 1 | 2019 | 272 | 0.150 | Why? | 
| Biomedical Research | 1 | 2022 | 400 | 0.150 | Why? | 
| Gene Knockdown Techniques | 2 | 2017 | 173 | 0.150 | Why? | 
| Estrogen Receptor alpha | 2 | 2015 | 111 | 0.140 | Why? | 
| Cell Line, Tumor | 5 | 2017 | 2231 | 0.140 | Why? | 
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.140 | Why? | 
| Androgen Antagonists | 1 | 2015 | 18 | 0.130 | Why? | 
| Spinal Cord | 1 | 2016 | 94 | 0.130 | Why? | 
| Protein Conformation | 2 | 2015 | 389 | 0.130 | Why? | 
| Prostate | 2 | 2015 | 154 | 0.130 | Why? | 
| Synapsins | 1 | 2014 | 7 | 0.130 | Why? | 
| Protein Transport | 2 | 2017 | 302 | 0.130 | Why? | 
| Molecular Structure | 2 | 2020 | 492 | 0.130 | Why? | 
| Microfilament Proteins | 1 | 2015 | 69 | 0.120 | Why? | 
| Plasmids | 3 | 2005 | 246 | 0.120 | Why? | 
| Affinity Labels | 1 | 2014 | 7 | 0.120 | Why? | 
| Chemistry, Pharmaceutical | 1 | 2014 | 71 | 0.120 | Why? | 
| Transcription Factor RelA | 1 | 2014 | 40 | 0.120 | Why? | 
| Two-Hybrid System Techniques | 1 | 2014 | 50 | 0.120 | Why? | 
| Mutation | 5 | 2014 | 1095 | 0.120 | Why? | 
| Chromatography, Affinity | 1 | 2014 | 67 | 0.120 | Why? | 
| Prefrontal Cortex | 1 | 2014 | 137 | 0.110 | Why? | 
| Lactams, Macrocyclic | 3 | 2013 | 8 | 0.110 | Why? | 
| Neoplasms | 2 | 2014 | 1103 | 0.110 | Why? | 
| Alternative Splicing | 1 | 2013 | 85 | 0.110 | Why? | 
| Benzoquinones | 3 | 2013 | 36 | 0.110 | Why? | 
| Transcriptional Activation | 4 | 2017 | 172 | 0.110 | Why? | 
| Estradiol | 1 | 2014 | 262 | 0.110 | Why? | 
| Gene Deletion | 3 | 2016 | 166 | 0.100 | Why? | 
| Disease Models, Animal | 2 | 2014 | 1371 | 0.100 | Why? | 
| Receptors, Mineralocorticoid | 1 | 2011 | 11 | 0.100 | Why? | 
| Neurosecretory Systems | 1 | 2011 | 16 | 0.100 | Why? | 
| Estrogen Receptor Modulators | 1 | 2011 | 19 | 0.100 | Why? | 
| Immunoprecipitation | 1 | 2011 | 131 | 0.100 | Why? | 
| Immunoblotting | 1 | 2011 | 176 | 0.100 | Why? | 
| Geologic Sediments | 1 | 2011 | 42 | 0.100 | Why? | 
| Hippocampus | 1 | 2014 | 561 | 0.100 | Why? | 
| Fluorescence | 1 | 2011 | 121 | 0.100 | Why? | 
| Sequence Homology, Amino Acid | 2 | 2010 | 269 | 0.090 | Why? | 
| DNA-Binding Proteins | 1 | 2014 | 539 | 0.090 | Why? | 
| Homeodomain Proteins | 1 | 2011 | 132 | 0.090 | Why? | 
| Infertility, Male | 1 | 2010 | 45 | 0.090 | Why? | 
| Depressive Disorder | 1 | 2011 | 174 | 0.090 | Why? | 
| Drug Design | 1 | 2011 | 162 | 0.090 | Why? | 
| Cell Proliferation | 2 | 2015 | 1198 | 0.090 | Why? | 
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 448 | 0.090 | Why? | 
| Chromatography, Liquid | 1 | 2010 | 142 | 0.090 | Why? | 
| Blotting, Western | 3 | 2011 | 859 | 0.080 | Why? | 
| Drug Delivery Systems | 1 | 2011 | 202 | 0.080 | Why? | 
| Transcription Factors | 1 | 2014 | 681 | 0.080 | Why? | 
| Adenosine Triphosphatases | 2 | 2012 | 82 | 0.080 | Why? | 
| Microtubules | 1 | 2010 | 120 | 0.080 | Why? | 
| tau Proteins | 1 | 2010 | 167 | 0.080 | Why? | 
| Dose-Response Relationship, Drug | 3 | 2011 | 1039 | 0.080 | Why? | 
| Phosphothreonine | 1 | 2007 | 5 | 0.080 | Why? | 
| Structural Homology, Protein | 1 | 2007 | 13 | 0.080 | Why? | 
| Circular Dichroism | 1 | 2007 | 62 | 0.080 | Why? | 
| Polymerase Chain Reaction | 2 | 2011 | 448 | 0.080 | Why? | 
| Steroids | 1 | 2007 | 43 | 0.070 | Why? | 
| Catalytic Domain | 1 | 2007 | 109 | 0.070 | Why? | 
| Point Mutation | 2 | 2005 | 93 | 0.070 | Why? | 
| Recombinant Proteins | 2 | 2010 | 515 | 0.070 | Why? | 
| Mice, Inbred C57BL | 4 | 2016 | 1609 | 0.070 | Why? | 
| Antineoplastic Agents | 1 | 2014 | 803 | 0.070 | Why? | 
| Sequence Alignment | 1 | 2007 | 265 | 0.070 | Why? | 
| Escherichia coli | 2 | 2010 | 453 | 0.070 | Why? | 
| Mice, SCID | 2 | 2017 | 150 | 0.070 | Why? | 
| Embryo Implantation | 1 | 2005 | 32 | 0.070 | Why? | 
| Immunohistochemistry | 3 | 2017 | 893 | 0.060 | Why? | 
| Uterus | 1 | 2005 | 55 | 0.060 | Why? | 
| Female | 7 | 2015 | 20969 | 0.060 | Why? | 
| Genotype | 2 | 2005 | 730 | 0.060 | Why? | 
| Xenograft Model Antitumor Assays | 2 | 2017 | 259 | 0.060 | Why? | 
| beta-Naphthoflavone | 1 | 2004 | 1 | 0.060 | Why? | 
| Phosphorylation | 1 | 2007 | 928 | 0.060 | Why? | 
| Transformation, Genetic | 1 | 2004 | 21 | 0.060 | Why? | 
| Quinones | 1 | 2004 | 14 | 0.060 | Why? | 
| Alzheimer Disease | 1 | 2011 | 905 | 0.060 | Why? | 
| Cell Nucleus | 2 | 2017 | 366 | 0.060 | Why? | 
| Gene Expression Regulation, Fungal | 1 | 2004 | 74 | 0.060 | Why? | 
| Down-Regulation | 1 | 2005 | 435 | 0.060 | Why? | 
| Vitellogenins | 2 | 2014 | 4 | 0.060 | Why? | 
| Cyprinidae | 2 | 2014 | 10 | 0.060 | Why? | 
| Temperature | 1 | 2004 | 286 | 0.050 | Why? | 
| Writing | 1 | 2022 | 37 | 0.050 | Why? | 
| Academies and Institutes | 1 | 2022 | 37 | 0.050 | Why? | 
| National Institutes of Health (U.S.) | 1 | 2022 | 88 | 0.050 | Why? | 
| Lac Operon | 1 | 2002 | 21 | 0.050 | Why? | 
| Brain | 1 | 2010 | 1346 | 0.050 | Why? | 
| Corticosterone | 2 | 2011 | 77 | 0.050 | Why? | 
| Fungal Proteins | 1 | 2002 | 140 | 0.050 | Why? | 
| Maze Learning | 2 | 2011 | 105 | 0.050 | Why? | 
| Anti-Bacterial Agents | 1 | 2003 | 352 | 0.050 | Why? | 
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 59 | 0.040 | Why? | 
| RNA, Messenger | 2 | 2014 | 1207 | 0.040 | Why? | 
| Ligands | 1 | 2019 | 349 | 0.040 | Why? | 
| HSP27 Heat-Shock Proteins | 1 | 2017 | 11 | 0.040 | Why? | 
| Rats | 2 | 2014 | 3483 | 0.040 | Why? | 
| Posterior Horn Cells | 1 | 2016 | 3 | 0.030 | Why? | 
| Flutamide | 1 | 2015 | 7 | 0.030 | Why? | 
| Dihydrotestosterone | 1 | 2015 | 29 | 0.030 | Why? | 
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.030 | Why? | 
| Neoplasm Proteins | 1 | 2017 | 213 | 0.030 | Why? | 
| Injections, Intralesional | 1 | 2014 | 11 | 0.030 | Why? | 
| Estrone | 1 | 2014 | 21 | 0.030 | Why? | 
| Mammary Glands, Human | 1 | 2015 | 39 | 0.030 | Why? | 
| Active Transport, Cell Nucleus | 1 | 2014 | 59 | 0.030 | Why? | 
| Phenotype | 1 | 2017 | 689 | 0.030 | Why? | 
| Repetitive Sequences, Amino Acid | 1 | 2014 | 8 | 0.030 | Why? | 
| Allosteric Regulation | 1 | 2014 | 22 | 0.030 | Why? | 
| Amino Acid Motifs | 1 | 2014 | 91 | 0.030 | Why? | 
| Oligopeptides | 1 | 2014 | 102 | 0.030 | Why? | 
| DNA Methylation | 1 | 2016 | 325 | 0.030 | Why? | 
| Behavior, Animal | 1 | 2014 | 314 | 0.030 | Why? | 
| Nerve Tissue Proteins | 1 | 2015 | 360 | 0.030 | Why? | 
| United States | 1 | 2022 | 4223 | 0.030 | Why? | 
| Oncogene Protein pp60(v-src) | 1 | 2012 | 10 | 0.030 | Why? | 
| Promoter Regions, Genetic | 1 | 2014 | 515 | 0.030 | Why? | 
| Tumor Cells, Cultured | 1 | 2013 | 502 | 0.030 | Why? | 
| Dexamethasone | 1 | 2011 | 45 | 0.020 | Why? | 
| Statistics, Nonparametric | 1 | 2011 | 108 | 0.020 | Why? | 
| Gene Expression | 1 | 2014 | 674 | 0.020 | Why? | 
| Transcription, Genetic | 1 | 2014 | 578 | 0.020 | Why? | 
| Corticotropin-Releasing Hormone | 1 | 2011 | 48 | 0.020 | Why? | 
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 807 | 0.020 | Why? | 
| Protein Structure, Secondary | 1 | 2012 | 183 | 0.020 | Why? | 
| Swimming | 1 | 2011 | 38 | 0.020 | Why? | 
| Exploratory Behavior | 1 | 2011 | 75 | 0.020 | Why? | 
| Inflammation | 1 | 2016 | 618 | 0.020 | Why? | 
| Water Supply | 1 | 2011 | 57 | 0.020 | Why? | 
| Embryo, Mammalian | 1 | 2011 | 153 | 0.020 | Why? | 
| Mental Disorders | 1 | 2014 | 309 | 0.020 | Why? | 
| Agriculture | 1 | 2011 | 56 | 0.020 | Why? | 
| Locomotion | 1 | 2011 | 97 | 0.020 | Why? | 
| Treatment Outcome | 1 | 2014 | 1369 | 0.020 | Why? | 
| Chymotrypsin | 1 | 2010 | 15 | 0.020 | Why? | 
| Cell Line | 1 | 2014 | 1354 | 0.020 | Why? | 
| Tissue Array Analysis | 1 | 2010 | 67 | 0.020 | Why? | 
| Xenopus | 1 | 2010 | 48 | 0.020 | Why? | 
| Cell Line, Transformed | 1 | 2010 | 91 | 0.020 | Why? | 
| Analysis of Variance | 1 | 2011 | 550 | 0.020 | Why? | 
| Linear Models | 1 | 2010 | 275 | 0.020 | Why? | 
| Oocytes | 1 | 2010 | 146 | 0.020 | Why? | 
| Emotions | 1 | 2011 | 220 | 0.020 | Why? | 
| Transfection | 1 | 2010 | 523 | 0.020 | Why? | 
| Motor Activity | 1 | 2011 | 418 | 0.020 | Why? | 
| Liver | 1 | 2011 | 479 | 0.020 | Why? | 
| Mutant Proteins | 1 | 2007 | 51 | 0.020 | Why? | 
| RNA, Small Interfering | 1 | 2010 | 409 | 0.020 | Why? | 
| Selection, Genetic | 1 | 2007 | 54 | 0.020 | Why? | 
| Cells, Cultured | 1 | 2011 | 1518 | 0.020 | Why? | 
| Catalysis | 1 | 2007 | 179 | 0.020 | Why? | 
| Polymorphism, Single Nucleotide | 1 | 2011 | 767 | 0.020 | Why? | 
| Drug Synergism | 1 | 2007 | 177 | 0.020 | Why? | 
| Case-Control Studies | 1 | 2010 | 1130 | 0.020 | Why? | 
| Time Factors | 1 | 2011 | 1742 | 0.020 | Why? | 
| Recombinant Fusion Proteins | 1 | 2007 | 295 | 0.020 | Why? | 
| Genetic Predisposition to Disease | 1 | 2010 | 628 | 0.020 | Why? | 
| Histological Techniques | 1 | 2005 | 14 | 0.020 | Why? | 
| Cohort Studies | 1 | 2010 | 1492 | 0.020 | Why? | 
| Blotting, Southern | 1 | 2005 | 69 | 0.020 | Why? | 
| In Situ Hybridization | 1 | 2005 | 129 | 0.020 | Why? | 
| Blotting, Northern | 1 | 2005 | 150 | 0.020 | Why? | 
| Aged, 80 and over | 1 | 2011 | 2379 | 0.020 | Why? | 
| Progesterone | 1 | 2005 | 113 | 0.020 | Why? | 
| Proline | 1 | 2005 | 43 | 0.020 | Why? | 
| Chaperonins | 1 | 2004 | 5 | 0.020 | Why? | 
| Genetic Vectors | 1 | 2005 | 158 | 0.020 | Why? | 
| Tissue Distribution | 1 | 2005 | 207 | 0.020 | Why? | 
| Models, Genetic | 1 | 2005 | 172 | 0.020 | Why? | 
| Substrate Specificity | 1 | 2004 | 212 | 0.010 | Why? | 
| Testis | 1 | 2005 | 187 | 0.010 | Why? | 
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 623 | 0.010 | Why? | 
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 187 | 0.010 | Why? | 
| Drosophila Proteins | 1 | 2004 | 171 | 0.010 | Why? | 
| Cell Cycle Proteins | 1 | 2004 | 229 | 0.010 | Why? | 
| Proteins | 1 | 2004 | 369 | 0.010 | Why? | 
| Young Adult | 1 | 2011 | 4268 | 0.010 | Why? | 
| Adult | 1 | 2011 | 11712 | 0.010 | Why? |